uniQure N.V.
QURE · Pharmaceutical Preparations
Latest available SEC filing: 4 ·
Latest disclosures
-
Meek David D.: Form 4
Insider disclosure · Filed · Report period 06 Nov 2026
-
Form 4
SEC filing · Filed
-
Latest financial period: Q3 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- QURE · N90064101 - Ordinary Shares, par value 0.05
Company details and SEC sources
CIK 0001590560 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- QURE on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- Paasheuvelweg 25 A, Amsterdam, 1105 BP
- Fiscal year end
- 31 December
- Former names on EDGAR
- uniQure B.V. (to 06 Feb 2014)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields